GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 36 filers reported holding GT BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $122 | – | 508 | +50700.0% | 0.00% | – |
Q2 2023 | $0 | -100.0% | 1 | -97.0% | 0.00% | – |
Q1 2023 | $18 | -71.9% | 33 | -54.2% | 0.00% | – |
Q4 2022 | $64 | -99.9% | 72 | -99.8% | 0.00% | – |
Q2 2022 | $124,000 | -12.7% | 41,282 | -16.6% | 0.00% | – |
Q1 2022 | $142,000 | -47.8% | 49,487 | -44.4% | 0.00% | – |
Q4 2021 | $272,000 | -53.3% | 88,975 | +2.9% | 0.00% | – |
Q3 2021 | $583,000 | +366.4% | 86,471 | +972.6% | 0.00% | – |
Q2 2021 | $125,000 | – | 8,062 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baskin Financial Services Inc. | 151,354 | $36 | 0.00% |
Moss Adams Wealth Advisors LLC | 20,000 | $4,822 | 0.00% |
UBS Group AG | 8,750 | $2,109 | 0.00% |
Compagnie Lombard Odier SCmA | 50,000 | $12,055 | 0.00% |
OSAIC HOLDINGS, INC. | 1,270 | $305 | 0.00% |
FMR LLC | 150 | $36 | 0.00% |
BANK OF AMERICA CORP /DE/ | 508 | $122 | 0.00% |
WELLS FARGO & COMPANY/MN | 300,697 | $72,498 | 0.00% |
NORTHERN TRUST CORP | 32,347 | $7,799 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |